Results

Total Results: 665 records

Showing results for "renal".

61. PSNet Curated Library (pdf file)
    psnet.ahrq.gov/print/pdf/node/842920
    December 14, 2022 - Renal Failure Due to Benign Prostatic Hyperplasia Michael J. Barry, MD, and Marc B. … anemia-and-delayed-colon-cancer-diagnosis https://psnet.ahrq.gov/web-mm/spinal-epidural-abscess https://psnet.ahrq.gov/web-mm/renal-failure-due-benign-prostatic-hyperplasia … Renal Failure Due to Benign Prostatic Hyperplasia Michael J. Barry, MD, and Marc B. … https://psnet.ahrq.gov/web-mm/anemia-and-delayed-colon-cancer-diagnosis https://psnet.ahrq.gov/web-mm/renal-failure-due-benign-prostatic-hyperplasia

62. XL or Smaller? | PSNet
    psnet.ahrq.gov/web-mm/xl-or-smaller
    September 13, 2017 - The Case With a history of hypertension and chronic renal failure secondary to hemolytic uremia syndrome … The intern admitting the patient spoke with the renal fellow to ask for advice concerning the hypertension … The renal fellow recommended giving the patient Procardia® (nifedipine) 30 mg by mouth. … IV fluids were started and the renal fellow was contacted. … When renal specialists refer to the extended-release drug Procardia XL, it is often called Procardia

63. Palliative Care: Comfort vs. Harm | PSNet
    psnet.ahrq.gov/web-mm/palliative-care-comfort-vs-harm
    December 04, 2016 - This is particularly relevant in patients with chronic organ failure like ischemic heart disease or renal … Dying of end-stage heart failure and renal failure can be relatively peaceful, but it may also require … In patients with renal failure, hydromorphone is an acceptable choice as it is mainly metabolized by … In general, and especially for a geriatric patient with renal insufficiency, opioid treatment should … Palliative care in end-stage renal disease: illness trajectories, communication, and hospice use.

64. Psn-Pdf (pdf file)
    psnet.ahrq.gov/node/49514/psn-pdf
    July 01, 2006 - He had no known renal dysfunction. … are generally well tolerated, like most drugs, their most worrisome adverse effects (hypotension, renal … dose of the offending drug(s), use of concomitant therapies, and comorbid illnesses, particularly renal … healthier patients, systematically excluding those with other risk factors for hyperkalemia (eg, advanced renal … prophylactic doses (eg, 5000 units BID) Nonsteroidal anti-inflammatory drugs Patients with compromised renal

65. Psn-Pdf (pdf file)
    psnet.ahrq.gov/node/60611/psn-pdf
    June 24, 2020 - factors including the indication (atrial fibrillation, VTE treatment, or VTE prevention), level of renal … syndrome, when compared with dual antiplatelet treatment.6   Assessment of DOAC use in End Stage Renal … Relevant variables, such as status of a patient’s renal function, can be determined from data already … Safety and efficacy of apixaban in patients with end-stage renal disease: Meta-Analysis. … Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease

66. A demonstration project on the impact of safety culture on infection control practices in hemodialysis | PSNet
    psnet.ahrq.gov/issue/demonstration-project-impact-safety-culture-infection-control-practices-hemodialysis
    May 01, 2024 - January 2, 2017 Medication dosing errors for patients with renal insufficiency in ambulatory … January 2, 2017 AHRQ Safety Program for End-Stage Renal Disease Facilities—Toolkit.

67. Complications of Vascular Access Procedures in Patients with Kidney Disease | PSNet
    psnet.ahrq.gov/web-mm/complications-vascular-access-procedures-patients-kidney-disease
    November 15, 2023 - Patient 1: A 31-year-old woman with end stage renal disease (ESRD) and pulmonary hypertension presented … some patients have an increased risk for adverse effects due to underlying comorbid conditions such as renal … advanced age, complicated baseline respiratory status, and drug interactions. 8  Given this patient’s poor renal … vascular access procedures but should be used cautiously in patients with comorbid conditions such as renal … WebM&M Cases Overdose of Gabapentin and Oxycodone in a Patient with End-Stage Renal

68. Spotlight
    psnet.ahrq.gov/sites/default/files/2024-08/spotlight_case_a_fatal_twist_in_pseudohyperkalemia_slides.pptx
    January 01, 2024 - Potassium (2) Hypokalemia, defined as serum potassium <3.5 mEq/L, can be caused by decreased intake, renal … changes, rapid-onset or severe hyperkalemia >6.5 mEq/L, or underlying heart disease, cirrhosis, or renal … hypokalemia exacerbated by transcellular shifts (from albuterol, insulin, and sodium bicarbonate), renal … Nonetheless, the physician should have reviewed the EHR to ascertain baseline renal function and any … combination of hyponatremia and hyperkalemia is explained by a limited number of conditions (e.g., renal

69. Psn-Pdf (pdf file)
    psnet.ahrq.gov/node/50696/psn-pdf
    November 27, 2019 - Patient 1: A 31-year-old woman with end stage renal disease (ESRD) and pulmonary hypertension presented … patients have an increased risk for adverse effects due to underlying comorbid conditions such as renal … advanced age, complicated baseline respiratory status, and drug interactions.8 Given this patient’s poor renal … procedural sedation; however, for patients with comorbid conditions affecting their respiratory status and renal … vascular access procedures but should be used cautiously in patients with comorbid conditions such as renal

70. Psn-Pdf (pdf file)
    psnet.ahrq.gov/node/49795/psn-pdf
    June 01, 2017 - However, out of concern for worsening the renal failure with contrast (i.e., contrast-induced nephropathy … Iodinated contrast media can cause kidney injury through direct cytotoxic effects on renal tissue.(1 … resulted in a growing elderly population with comorbidities such as hypertension, diabetes mellitus, renal … disease, and cardiovascular disease, all of which predispose to renal impairment. … contrast media.(6) The risk in the setting of chronic kidney disease depends on the degree of baseline renal

71. One ACE Too Many | PSNet
    psnet.ahrq.gov/web-mm/one-ace-too-many
    June 21, 2016 - He had no known renal dysfunction. … inhibitors are generally well tolerated, like most drugs, their most worrisome adverse effects (hypotension, renal … the dose of the offending drug(s), use of concomitant therapies, and comorbid illnesses, particularly renal … healthier patients, systematically excluding those with other risk factors for hyperkalemia (eg, advanced renal … (eg, 5000 units BID) Nonsteroidal anti-inflammatory drugs Patients with compromised renal

72. Psn-Pdf (pdf file)
    psnet.ahrq.gov/node/49511/psn-pdf
    May 01, 2006 - psnet.ahrq.gov/web-mm/citrate-mix The Case A 36-year-old woman with multiple sclerosis, diabetes, and chronic renal … In spite of the patient's pre-existing renal disease and diabetes, no permanent harm resulted; the outcome … example, the Institute for Safe Medication Practices (ISMP) reported a case of a 15-month-old child with renal … system may be tailored to screen the patient's laboratory values (serum potassium) and disease states (renal

73. Direct Oral Anticoagulants are High-Risk Medications with Potentially Complex Dosing | PSNet
    psnet.ahrq.gov/web-mm/direct-oral-anticoagulants-are-high-risk-medications-potentially-complex-dosing
    August 21, 2005 -  factors including the indication (atrial fibrillation, VTE treatment, or VTE prevention), level of renal … syndrome, when compared with dual antiplatelet treatment. 6    Assessment of DOAC use in End Stage Renal … Relevant variables, such as status of a patient’s renal function, can be determined from data already … Safety and efficacy of apixaban in patients with end-stage renal disease: Meta-Analysis. … Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on

74. Hearing: Broken Promises: Assessing VA’s Systems for Protecting Veterans from Clinical Harm. | PSNet
    psnet.ahrq.gov/issue/hearing-broken-promises-assessing-vas-systems-protecting-veterans-clinical-harm
    December 23, 2012 - September 2, 2016 Hearing on Patient Safety and Quality Issues in End Stage Renal Disease … May 1, 2015 Hearing on Patient Safety and Quality Issues in End Stage Renal Disease Treatment

75. The Perils of Contrast Media | PSNet
    psnet.ahrq.gov/web-mm/perils-contrast-media
    March 01, 2007 - However, out of concern for worsening the renal failure with contrast (i.e., contrast-induced nephropathy … Iodinated contrast media can cause kidney injury through direct cytotoxic effects on renal tissue.( 1 … resulted in a growing elderly population with comorbidities such as hypertension, diabetes mellitus, renal … disease, and cardiovascular disease, all of which predispose to renal impairment. … contrast media.( 6 ) The risk in the setting of chronic kidney disease depends on the degree of baseline renal

76. PowerPoint Presentation (ppt file)
    psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.332_slideshow.ppt
    September 01, 2014 - morphine and hydromorphone, are mainly eliminated in the urine; may need to adjust dose in setting of renal … He was found to have new acute renal insufficiency, which likely had contributed to a build-up of opioids … pubmed/23553809 17 Predictors of Opioid-Related Adverse Events Patient-related factors Age Obesity Renal … morphine equivalents Use of multiple opioid drugs Co-prescription of other sedating medications (diazepam) Renal … hydromorphone instead of morphine likely contributed Doses should have been reduced in the setting of renal

77. Psn-Pdf (pdf file)
    psnet.ahrq.gov/node/866618/psn-pdf
    December 31, 2024 - changes, rapid-onset or severe hyperkalemia >6.5 mEq/L, or underlying heart disease, cirrhosis, or renal … hypokalemia exacerbated by transcellular shifts (from albuterol, insulin, and sodium bicarbonate), renal … associated hyperkalemia with the patient’s recently modified dietary intake in conjunction with poor renal … Nonetheless, the physician should have reviewed the EHR to ascertain baseline renal function and any … combination of hyponatremia and hyperkalemia is explained by a limited number of conditions (e.g., renal

78. Clinician collaboration to improve clinical decision support: the Clickbusters initiative. | PSNet
    psnet.ahrq.gov/innovation/clinician-collaboration-improve-clinical-decision-support-clickbusters-initiative
    October 21, 2020 - July 29, 2020 Renal medication-related clinical decision support (CDS) alerts and overrides … March 17, 2021 Renal medication-related clinical decision support (CDS) alerts and overrides

79. Psn-Pdf (pdf file)
    psnet.ahrq.gov/node/49730/psn-pdf
    April 01, 2015 - initially required intensive care unit admission for urgent hemodialysis before having a return of renal … The inpatient team desired a 1-week follow-up appointment to check renal function, potentially re-start … medications held during hospitalization because of the renal failure, and ensure entry into the primary … Once his renal function was assessed and found to be back to baseline, his previously held antihypertensives

80. Diagnosing a Missed Diagnosis | PSNet
    psnet.ahrq.gov/web-mm/diagnosing-missed-diagnosis
    October 26, 2022 - lithium use for treatment of bipolar or mood disorders is associated with several different types of renal … nephrotic syndrome from minimal change disease or focal segmental glomerulosclerosis.( 1 ) The most common renal … cause it.( 2,3 ) Up to 60% of lithium filtered by the kidney is reabsorbed, mainly by the proximal renal … Take-Home Points Chronic lithium use is associated with renal toxicity, most commonly nephrogenic